Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
16.93
+0.01 (0.06%)
Jul 15, 2026, 4:00 PM EDT - Market closed
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $877.45 million as of July 15, 2026. Its market cap has increased by 59.10% in one year.
Market Cap
877.45M
Enterprise Value
523.29M
1-Year Change
59.10%
Ranking
Category
Stock Price
$16.93
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has increased from $740.70M to $877.45M, an increase of 18.46%. That is a compound annual growth rate of 1.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 872.80M | -7.94% |
| Dec 31, 2025 | 948.10M | 104.91% |
| Dec 31, 2024 | 462.70M | -17.33% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
| May 16, 2014 | 740.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 950.29M |
| Design Therapeutics | 948.72M |
| Arbutus Biopharma | 948.18M |
| LB Pharmaceuticals | 944.90M |
| Faeth Therapeutics | 932.16M |
| Alto Neuroscience | 929.29M |
| Replimune Group | 922.56M |
| Tenax Therapeutics | 896.66M |